RidaWorm 500mg Film-Coated Tablets for Dogs

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Toimeaine:

Nitroscanate

Saadav alates:

Chanelle Pharmaceuticals Manufacturing Ltd

ATC kood:

QP52AX01

INN (Rahvusvaheline Nimetus):

Nitroscanate

Ravimvorm:

Film-coated tablet

Retsepti tüüp:

NFA-VPS - Non-Food Animal – Veterinarian, Pharmacist, Suitably Qualified Person

Terapeutiline rühm:

Dogs

Terapeutiline ala:

Anthelmintic anticestodal

Volitamisolek:

Expired

Loa andmise kuupäev:

2019-05-30

Toote omadused

Issued: May 2019
AN: 01548/2015
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
RidaWorm 500mg Film-Coated Tablets for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH TABLET CONTAINS
ACTIVE SUBSTANCES:
Nitroscanate
500 mg
EXCIPIENT(S):
Titanium Dioxide (E171) 3.950 mg
Ferric Oxide Yellow (E172) 0.1306 mg
Ferric Oxide Black (E172) 0.00013 mg
Ferric Oxide Red (E172) 0.00013 mg
As constituents of Opadry OY-GM 7900
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Round convex tablets, yellow coloured, film coated.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of the following cestodes (tapeworms) and intestinal
nematodes
(roundworms):
NEMATODES:
ASCARIDS: _Toxocara canis _(adult parasite stage)
HOOKWORMS:
_Ancylostoma caninum _(adult parasite stages)_ _
CESTODES
_Taenia_ species (_T. hydatigena, T. pisiformis_, _T. _ovis) (adult
and immature
parasite stages) and _Dipylidium caninum _(adult parasite stage).
4.3
CONTRAINDICATIONS
Do not administer to dogs that are sick or recovering from an illness.
Do not use in known cases of hypersensitivity to the active substance
or to
any of the excipients.
Do not use in dogs weighing less than 10 kg.
Issued: May 2019
AN: 01548/2015
Page 2 of 5
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Since the most common tapeworm of the dog (_Dipylidium caninum_) is
transmitted by a flea and has a very short pre-patent period, it is
important to pay
attention to flea control to reduce the incidence of tapeworm in the
animal._ _
The advice of a veterinary surgeon, pharmacist or Suitably Qualified
Person
(SQP) should be sought regarding the need for and frequency of repeat
treatment.
4.5
SPECIAL PRECAUTIONS FOR USE
i
Special precautions for use in animals
The product should not be administered to puppies less than 6 months
old,
owing to the need to restrict food intake at the time of
administration. See
also section 4.9.
If a hypersen